Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999 Feb;90(2):425-31.
doi: 10.1097/00000542-199902000-00016.

Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration

Affiliations
Clinical Trial

Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration

A F Kopman et al. Anesthesiology. 1999 Feb.

Erratum in

  • Potency of cisatracurium: a correction.
    Kopman AF, Neuman GG, Klewicka MM. Kopman AF, et al. Anesthesiology. 2000 May;92(5):1507. doi: 10.1097/00000542-200005000-00065. Anesthesiology. 2000. PMID: 10781312 No abstract available.

Abstract

Background: The times to peak effect of rocuronium, vecuronium, cisatracurium, mivacurium, and succinylcholine were evaluated to confirm that the correlation between potency and onset time observed for long-acting relaxants also held for drugs of intermediate and short duration.

Methods: The authors recruited 99 patients classified as American Society of Anesthesiologists physical status score 1 or 2 for the study. After anesthesia was induced, tracheal intubation was accomplished without relaxants. Anesthesia was maintained with nitrous oxide and 3% or 4% end-tidal desflurane plus intravenous narcotic supplementation. The evoked electromyographic response to single stimuli administered at 0.10 Hz was recorded continuously. Drug doses were selected to produce approximately 95% twitch depression. If peak twitch depression did not fall in the range of 90% to 98%, the patient was excluded from the study. The time to 50% to 90% of peak effect was plotted as a function of the administered dose.

Results: There was no difference in the onset profiles of mivacurium and vecuronium, or in the time to 50% of peak effect between succinylcholine and rocuronium. For all other parameters, onset times ranked as follows: succinylcholine < rocuronium < vecuronium-mivacurium < cisatracurium (P < 0.05). When the log of the ED95 in micromoles per kilogram for all five drugs was plotted against the log of onset time to 50% peak effect, the R2 value for the best fit line was more than 0.98.

Conclusions: The inverse correlation between the molar potency and speed of onset previously described for agents of long duration also applies to nondepolarizing agents of intermediate and short duration. The onset time of succinylcholine also appears to be compatible with this relation.

PubMed Disclaimer

Comment in

  • Potency of cisatracurium: a correction.
    Kopman AF, Neuman GG, Klewicka MM. Kopman AF, et al. Anesthesiology. 2000 May;92(5):1507. doi: 10.1097/00000542-200005000-00065. Anesthesiology. 2000. PMID: 10781312 No abstract available.
  • The intubating dose of succinylcholine.
    Kopman AF. Kopman AF. Anesthesiology. 2002 Feb;96(2):516; author reply 517. doi: 10.1097/00000542-200202000-00050. Anesthesiology. 2002. PMID: 11818795 No abstract available.

Publication types

LinkOut - more resources